Metabolomic analysis for first-trimester trisomy 18 detection

American Journal of Obstetrics and Gynecology

Volumn 209, Issue 1, 2013, Pages 65.e1-65.e9

  Bahado Singh, Ray O ^a   Akolekar, Ranjit ^b   Chelliah, Anushka ^c   Mandal, Rupasri ^d   Dong, Edison ^d   Kruger, Michael ^c   Wishart, David S ^d   Nicolaides, Kypros ^b  

^a OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Metabolomics; Screening; Trisomy 18

Indexed keywords

BIOLOGICAL MARKER; GLYCEROL; HYDROXYBUTYRIC ACID; TRIMETHYLAMINE;

ADULT; ANEUPLOIDY; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MATERNAL AGE; MATERNAL SERUM; METABOLITE; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; PREGNANCY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRISOMY 18; TRISOMY 21;

EID: 84880134365     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.03.028     Document Type: Article

References (16)

1. Psychogios N, Hau DD, Peng J, et al. The human serum metabolome. PLoS One 2011;6: E16957.
2. Mandel R, Guo HC, Chaudhary KK, et al. Multiplatform characterization of the human cerebrospinal fluidmetabolome: A comprehensive and quantitative update. Genome Med 2012;4:38.
3. Xu XH, Huang Y, Wang G, Chen SD. Metabolomics: A novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease. Neurosci Bull 2012;28:641-8.
4. Kenny LC, Broadhurst DI, Dunn W, et al. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension 2010;56:741-9.
5. Romero R, Mazaki-Tovi S, Kusanovich JP, et al. Metabolomics in premature labor: A novel approach for identifying patients at risk for preterm delivery. J Matern Fetal Neonatal Med 2010;23:1344-59.
6. Odibo AO, Goetzinger KR, Odibo L, Cahill AG, Macones GA. First-trimester prediction of preeclampsia using metabolomic biomarkers: A discovery phase study. Prenat Diagn 2011;31: 990-4.
7. Bahado-Singh RO, Akolekar R, Mandal R, et al. Metabolomics and first trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med 2012;25:1840-7.
8. Bahado-Singh R, Akolekar R, Mandal R, et al. Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol 2013;208:371.e1-8.
9. Kagan KO, Wright D, Maiz N, Pandeva I, Nicolaides KH. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008;32: 488-92.
10. National Institute for Health and Care Excellence (NICE). Antenatal care: Routine care for the healthy pregnant woman. NICE guideline 2008. Available at: www.guidance.nice.org.uk. Accessed April 23, 2013.
11. American College of Obstetricians and Gynecologists. Screening for fetal chromosomal abnormalities. ACOG practice bulletin no. 77. Obstet Gynecol 2007;109:217-27.
12. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008;31:376-83.
13. Xia J, Mandal R, Sineinkov IV, Broadhurst D, Wishart D. MetaboAnalyst 2.0: A comprehensive server for metabolomic data analysis. Nucleic Acids Res 2012;40:W127-33.
14. Wishart DS. Computational approaches to metabolomics methods. Mol Biol 2010;593: 283-313.
15. Goodcare R. Making sense of the metabolome using evolutionary computation: Seeing the wood with the trees. J Exp Bot 2005;56: 245-54.
16. Wishart DS, Knox C, Guo AC, et al. HMDB: A knowledgebase for the human metabolome. Nucleic Acids Res 2009;37:D603-10.